4 completed, 2 unknown. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Unknown 2 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow oxybutynin: new trials by email Literature Review of oxybutynin trials Research Report on oxybutynin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea Atomoxetine 80 mg plus Oxybutynin 5 mg, Atomoxetine 80 MG, Placebo - OSA | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 27 | 2023-12-01 | 2025-12-17 |
| Effectiveness of Oral Boldo in Women With Overactive Bladder Oxybutynin Pill, Boldo supplement - Urinary Bladder, Overactive | Phase 1 | Unknown | Universidad de Valparaiso | 10 | 2023-11-01 | 2023-12-08 |
| Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy Atomoxetine, Oxybutynin - Obstructive Sleep Apnea | Phase 1 / Phase 2 | Unknown | Brigham and Women's Hospital | 22 | 2022-05-05 | 2023-10-18 |
| Atomoxetine and Oxybutynin in Obstructive Sleep Apnea Combination product of Atomoxetine and Oxybutynin, Placebo, 2 tablets - Obstructive Sleep Apnea (OSA) | Phase 1 / Phase 2 | Completed | Brigham and Women's Hospital | 22 | 2016-09-01 | 2019-01-29 |
| Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity Oxytocin, Lorazepam 1 mg, Placebo nasalspray - Oxytocin, Lorazepam, Anti-Anxiety Agents, Physiological Effects of Drugs | Phase 1 | Completed | University Hospital, Bonn | 120 | 2016-03-03 | 2019-04-17 |
| A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder solabegron and oxybutynin - Overactive Bladder | Phase 1 | Completed | GlaxoSmithKline | 24 | 2007-06-01 | 2015-04-15 |
Sleep Apnea, Obstructive (2) · Urinary Bladder, Overactive (2) · Anxiety Disorders (1)
Brigham and Women's Hospital (3) · GlaxoSmithKline (1) · Universidad de Valparaiso (1) · University Hospital, Bonn (1)
United States (4) · Chile (1) · Germany (1)
Scott A Sands, PhD (2) · Dillon Gilbertson (1)